Key points
- NIOSH co-sponsors grants for the Small Business Innovation Research (SBIR) program.
- SBIR helps businesses commercialize innovations from federal research.
- Interested applicants are encouraged to review the list of NIOSH topics.
Background
The HHS Small Business Innovation Research (SBIR) program is a partnership among federal agencies. The Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health participate. The goals of the program are to:
- Stimulate technological innovation
- Meet federal research and development needs
- Increase private sector commercialization of innovations developed through federal R&D funding
- Foster and encourage participation in innovation and entrepreneurship.
NIOSH participates by funding SBIR grants related to occupational safety and health.
Funding by category
SBIR is a phased program. The main objective Phase I is to establish the technical merit and feasibility of the proposed research and development efforts. Phase II continues the R&D efforts to advance the technology toward ultimate commercialization. At the end of Phase II, small businesses are expected to fully commercialize their product or technology using non-SBIR funds. These funds could be either federal or non-federal.
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.